NTS Ventures and IHMA Announce a Collaborative Agreement to Provide an Extensive Suite of Clinical Mycology, Antifungal and Microbiology Laboratory Services to Support Anti-infective Drug Development to the Biopharmaceutical Industry

SCHAUMBURG, Ill., Dec. 04, 2017 (GLOBE NEWSWIRE) — NTS Ventures (NTS), a mycology and antifungal clinical research laboratory and International Health Management Associates, Inc./IHMA Europe Sàrl (IHMA), a full-service central clinical microbiology laboratory have announced a non-exclusive collaborative agreement that will provide the pharmaceutical industry …

Read More

SpeeDx Pty. Ltd. establishes US-based operation

Subsidiary prepares for expected 2018 US product launch

SYDNEY, Australia, Dec. 04, 2017 (GLOBE NEWSWIRE) — SpeeDx Pty. Ltd, a developer of advanced multiplex molecular diagnostic solutions, announced the incorporation of a US-based subsidiary company, SpeeDx Inc.   The parent company, headquartered in Australia, will use …

Read More